DBC-1 Antibodies

Santa Cruz Biotechnology delivers a wide array of DBC-1 monoclonal antibodies for research focused on understanding DBC-1's role in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DBC-1, or Deleted in Breast Cancer 1, plays a crucial role in regulating cell growth and apoptosis, particularly in cancer development. As a tumor suppressor, DBC-1 represents a significant area of study for understanding cancer progression and developing therapeutic interventions. Research on DBC-1 continues to reveal important insights into the mechanisms of breast cancer and other malignancies, highlighting its significance in cancer biology. DBC-1 has been shown to interact with several key cellular proteins, influencing various signaling pathways involved in cell survival and death. Recent studies have demonstrated DBC-1's involvement in DNA damage response and cellular stress pathways. Understanding the molecular mechanisms of DBC-1 function could lead to new therapeutic strategies for cancer treatment. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of cancer biology and contribute to the development of new therapeutic approaches.